MARKET

SUPN

SUPN

Supernus Pharma
NASDAQ
45.68
+0.58
+1.29%
After Hours: 45.68 0 0.00% 17:01 12/05 EST
OPEN
44.94
PREV CLOSE
45.10
HIGH
45.88
LOW
44.51
VOLUME
458.56K
TURNOVER
--
52 WEEK HIGH
57.65
52 WEEK LOW
29.16
MARKET CAP
2.62B
P/E (TTM)
-134.0376
1D
5D
1M
3M
1Y
5Y
1D
3 Unprofitable Stocks We Find Risky
Barchart · 2d ago
Supernus Pharmaceuticals to Present at Bank of America Securities CNS Therapeutics Virtual Conference
Reuters · 2d ago
Supernus Pharmaceuticals to Participate in the Bank of America Securities 2025 CNS Therapeutics Virtual Conference
Barchart · 3d ago
Bank of America Highlights Five Stocks It Says Still Offer Clear Upside in 2025
TipRanks · 5d ago
Weekly Report: what happened at SUPN last week (1124-1128)?
Weekly Report · 5d ago
Weekly Report: what happened at SUPN last week (1117-1121)?
Weekly Report · 11/24 09:46
1 Healthcare Stock Worth Your Attention and 2 Facing Headwinds
Barchart · 11/24 03:36
Supernus Pharmaceuticals to Join Piper Sandler Annual Healthcare Conference
Reuters · 11/21 21:06
More
About SUPN
Supernus Pharmaceuticals, Inc. is a biopharmaceutical company focused on developing and commercializing products for the treatment of central nervous system (CNS) diseases. The Company’s diverse neuroscience portfolio includes approved treatments for attention-deficit hyperactivity disorder (ADHD), dyskinesia in Parkinson’s disease (PD) patients receiving levodopa-based therapy, hypomobility in PD, postpartum depression (PPD), epilepsy, migraine, cervical dystonia, and chronic sialorrhea. It is also developing a range of product candidates for CNS disorders. Its commercial products that it markets include Qelbree, GOCOVRI, Oxtellar XR, Trokendi XR, APOKYN, XADAGO, MYOBLOC and ONAPGO. Its ONAPGO injection is a subcutaneous apomorphine infusion device for the treatment of motor fluctuations in adults with advanced PD. It also offers ZURZUVAE (zuranolone) capsules CIV, which is a U.S. FDA-approved oral medicine indicated for the treatment of adults with postpartum depression.

Webull offers Supernus Pharmaceuticals Inc stock information, including NASDAQ: SUPN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, SUPN stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading SUPN stock methods without spending real money on the virtual paper trading platform.